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Self-managed abortion (SMA) is not a new
phenomenon but occurs across histories1 and
social and legal contexts,2 utilising a range of
methods.1 SMA is broadly understood as actions
or activities undertaken by a pregnant individual
to end a pregnancy outside of clinical settings,
but there is considerable debate around how
SMA is understood. These debates are under-
pinned by a range of approaches, politics and
standpoints. Language use also varies (e.g. self-
administered or self-care), reflecting the types of
technologies or individuals involved.
The steady increase in the use of medical abor-
tion (MA) drugs – misoprostol and mifepristone –
has enabled safer self-management and self-use,
centring autonomy, privacy and confidentiality,
while also contributing to the reduction of abor-
tion-related morbidity and mortality globally.3,4
MA has increasingly been included as an element
of sexual and reproductive health interventions
and is gaining greater consideration within
notions of self-care.5 The advent of telehealth
and the growing network of organisations sup-
porting safe self-use has fundamentally altered
the abortion landscape.6–9 This is also evident in
the temporary shift from some governments
during the COVID-19 pandemic, allowing abortion
via telemedicine 9–11 or “pills by post”.12 Medical
societies and organisations13 have also called for
a similar shift to provision via telemedicine.14
We understand “telemedicine” as the provision
of remote clinical services through formal sys-
tems, while “telehealth” covers a broad range of
health activities (e.g. health promotion activities)
that are provided remotely through technology
and other platforms. We acknowledge (and agree
with) feminist groups’ disagreement around
accompaniment models, information or safe
abortion hotlines being classified as “telemedi-
cine”, especially as their approaches directly chal-
lenge the medicalisation of abortion.
These shifts in the abortion landscape demon-
strate how SMA – through the use of MA – chal-
lenges binary conceptualisations of abortion
safety,15 unsettling heavily medicalised notions
of what safe conditions are and who a provider
is. By enabling and centring the needs and
autonomies of abortion-seekers, SMA reclaims
abortion autonomy as a feminist political
demand.16,17 Yet rather than a solely individual
act, pregnant persons’ SMA trajectories are shaped
and influenced by a number of actors at different
points along their journey. These actors, function-
ing locally and nationally, as well as transnation-
ally, enable SMA access and provide different
types of support.17 For example, feminist actors
on the ground and the networks procuring pills,
disseminating information and providing assist-
ance over the course of people’s abortion trajec-
tories have enabled SMA.18,19 They have also,
*Lucía Berro Pizzarossa and Rishita Nandagiri equally drafted,
contributed to, and reviewed this article and share joint first
authorship.
COMMENTARY
1© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, pro-
vided the original work is properly cited.
through these efforts, shifted understandings of
self-induced abortion from “risky”, “unsafe”,
“back alley abortions” to a notion of “self-care”
and a reconceptulisation of “safety”.16 As govern-
ments enact strict anti-abortion laws (e.g. Poland,
USA), are unable to provide full-spectrum abortion
care (e.g. Ireland), or where overburdened health
systems, whether due to the pandemic or chronic
underfunding, cannot provide adequate care, it is
a range of formal and informal actors – hotlines,
feminist networks, accompaniment groups, dou-
las, pharmacists or other community health
workers – who step in to provide care, sometimes
across borders.20 Providing critical information
and support, these actors are made vulnerable
and exposed to social and legal risks because of
their work around SMA. They experience direct
criminalisation and/or risk of imprisonment due
to contravention of a related, but not abortion-
specific, law (e.g. illegal pharmacy practices) or
experience increased surveillance and harassment
(e.g. criminalising a mother for procuring MA for
her underage daughter), among other threats
and risks to their lives and livelihoods.
Understandings of SMA, while continuing to
centre the needs of those seeking an abortion,
need to expand to account for, acknowledge and
consider how these actors and their roles are
theorised, supported and understood. These shifts
and changes in the abortion landscape are not
reflected in the way abortion continues to be leg-
ally framed and regulated, requiring a deeper
consideration of the ecology of abortion care-
seeking and care-provision (including SMA), its
contexts and its actors.
Thus, we define self-management of abortion
as consisting of a range of individual activities –
a multiplicity of behaviours and navigations that
surround abortion self-use (e.g. self-sourcing,
potentially necessitating (unpaid) leave from
work, arranging childcare and management of
symptoms or complications, confirmation of abor-
tion), and the collective dimension that enables
safe self-use through a constellation of actors
and interlocutors (e.g. friends, partners, family
members, community health intermediaries,
pharmacists, activists, non-profit organisations,
hotline operators, accompaniment networks, dou-
las) who undertake a number of activities (e.g.
provision of accurate information, sourcing of
pills, accompaniment through the process, child-
care provision) to support peoples’ SMA trajec-
tories.16 In this commentary, while recognising
the spectrum of methods and approaches used
to self-manage an abortion, we speak largely to
SMA using MA and focus on those actors who sup-
port womxn (we use “womxn” or “pregnant per-
sons” as transmen and non-binary persons,
along with women and girls, need or require
abortions).
A constellation of actors?
Discussions on SMA have largely focused on its
potential for womxn’s agencies and realising
reproductive freedoms,21 shifting away from a
medicalised and paternalistic model of abortion
care.22 This justified individual focus on womxn,
however, overlooks the essential collective of
actors, processes and communities that surround,
enable and support this claiming and enacting of
agencies. Some, in this broad constellation of
actors, can also work to enact barriers to abortion
care and self-management.
This constellation of actors involves persons,
groups and collectives working in/formally and
il/legally, and at different points in womxn’s tra-
jectories to enable or restrict SMA.16 A non-
exhaustive mapping would include, starting with
the pregnant persons themselves: feminist groups,
accompaniment networks, abortion hotlines, full-
spectrum doulas, friends, partners or family mem-
bers, community health workers, websites sharing
abortion information, clinic escorts, pharmacists
or other friendly providers and many others that
we may not have yet considered. It includes
anti-abortion groups and actors who attempt to
misdirect or remove SMA access. Individuals and
groups who may not align themselves with anti-
abortion ideologies, but nonetheless hold stigma-
tising beliefs or are misinformed about abortion,
may also further abortion stigma, affecting
womxn’s trajectories and experiences including
SMA.
At the individual or interpersonal level, evi-
dence shows that social networks are essential to
SMA. In India, for example, the majority of abor-
tions are estimated to be medical abortions occur-
ring outside formal health facilities.23 Men play an
important role in purchasing pills for their part-
ners,24 and lay community health intermediaries
can offer crucial interventions including infor-
mation or procuring pills. These may involve
some health workers, like pharmacists for
example, working outside their legal and pro-
fessional remit to cater to individual needs.25 It
L Berro Pizzarossa, R Nandagiri. Sexual and Reproductive Health Matters 2021;29(1):1–8
2
may also involve, where restrictions have been
enforced, illegal vendors, as observed in Brazil
and other countries.6 The role of pharmacists
and cadres of community health workers in MA
has received increasing attention, particularly in
contexts where abortion is legal.26–28 These task-
sharing roles, however, remain largely conceptu-
alised within formal spaces rather than SMA.25
This is despite evidence that pharmacists and lay
community health intermediaries play important
roles in SMA outside of formal spaces, blurring
the line between formal and informal abortion
service and information provision.2,24
At the community and social networks level,
the role of feminist networks and organisations
in enabling access cannot be overstated. Even
before the pandemic, feminist accompaniment
networks, abortion hotlines and websites were
catering to essential abortion needs 6,7,29,30
which have become a lifeline during lockdown.31
Staffed by trained workers and volunteers, these
support systems often provide information and
services where none are otherwise available or
accessible including due to legal restrictions.6,8,29
Apart from providing crucial counselling and sup-
port, they also normalise and validate womxn’s
abortion needs and SMA experiences.29,32 As
exemplified by the Socorristas in Argentina, the
accompaniment model provides support over
the course of the abortion trajectory. Their work
also includes supporting self-management of
second-trimester abortions,33 involving a range
of activists and experts from trained telephone
operators and pharmacists to collective knowl-
edge-sharing of experts, links with formal care-
providers if needed and provision of post-abortion
follow-up by trained clinicians. All of these differ-
ent actors enable self-management, forming that
essential constellation of actors who provide infor-
mation, accompaniment, medication, support,
counselling and post-abortion care including
referrals for a range of needs (e.g. psychological
care, support for survivors of violence). Without
them, SMA would likely involve greater levels of
risk, be harder to access and womxn might resort
to more unsafe methods.
Google searches for abortion pills have more
than doubled in the last decade, especially in con-
texts where abortion is legally restricted.34 Abor-
tion websites and those who write the content
and keep it updated do not just provide accurate
(and often hard-to-find) abortion information,20
including on SMA, but are tasked with signposting
other necessary resources (especially when things
are fast-changing or where government restric-
tions may make it a target for shutdown), as
well as actively identifying and warning against
misinformation and proliferation of harmful,
fake pills.35 They also contend with overzealous
moderation of social media sites leading to sus-
pensions36 or blocking of websites.37 Websites
and social media accounts, often run by feminist
networks, also offer emotional, legal and practical
support for womxn, especially when they may
need to safeguard secrecy around abortion for
safety or legal reasons. As technology and internet
access has improved, feminist groups have also
turned to using messaging apps to provide infor-
mation and support.38This too requires training,
skills and resources. This existing infrastructure
has been a boon during the COVID-19 pandemic,
with many womxn accessing help without com-
promising their personal privacy or safety.39 The
support provided across these mediums can
extend from linking access to care, explaining
what symptoms or signs womxn may experience
to validating their decisions.40,41 This work in
enabling safe abortion access exceeds just the pro-
vision of information or services alone but con-
tributes to an environment in which womxn can
exercise their autonomies fully informed and in
a safe manner.
All these actors are exposed to risk (legal, social,
physical and emotional, in addition to personal
and collective risk) and carry an increased burden
of responsibilities in their work to enable SMA.
While there have been efforts to consider how for-
mal abortion providers are stigmatised or experi-
ence risk,42 there is little understanding of the
stigma, vulnerabilities and risks this constellation
of actors are exposed to. These actors – and the
risks they experience and burdens they carry –
remain hidden within SMA narratives, despite
being crucial players in womxn’s SMA trajectories
and experiences.
The constellation also includes anti-abortion
actors and groups, from those spreading anti-
abortion myths on social media to funded web-
sites deliberately seeking to misdirect abortion-
seekers,43,44 or using technology to block access
through misinformation and lies.45 Advertise-
ments may also contain inaccurate or misleading
information on abortion46 and may, like so-called
“crisis pregnancy centres”, co-opt feminist
language in their misdirection efforts.14 Overlook-
ing these groups and actors within the abortion
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ecology is dangerous, particularly in light of
increased efforts to restrict abortion globally.
Even in the midst of a pandemic, a UK anti-abor-
tion group conducted a bogus study to discredit
telemedicine,47 taking the British Pregnancy Advi-
sory Service to court and losing an appeal against
the at-home abortion service. These tactics con-
tribute to the misinformation and stigma around
at-home abortions, feeding into the continued
medicalisation of abortion and increasing the
risk womxn are exposed to. It also stigmatises indi-
viduals and groups working on and providing
abortion access. Apart from their negative impact
on abortion-seekers, such efforts waste feminist
groups’ scarce resources and time, especially
when fighting spurious accusations that threaten
to limit abortion care.
A cacophony of laws?
Abortion laws, even in their “best” constructions,
set burdensome requirements for access.48 Even
new laws that bring about liberalisation of abor-
tion still propose a model of criminalisation or
medicalisation of SMA and as such create vulner-
abilities and risks for those engaged in the
practice.
Under most current laws, people that self-man-
age and those who provide them with infor-
mation, support or accompaniment risk arrest,
police harassment or bribery, prosecution and
imprisonment. Indeed, laws such as the Urugua-
yan49 or South African50 laws that are considered
ground-breaking, still criminalise those who self-
manage their abortions. These laws are part of
the majority of laws that require medical involve-
ment (multiple medical professionals in these two
cases) and specifically criminalise those that pro-
cure abortions outside of the process set up in
the law, while simultaneously placing very bur-
densome barriers to access.51 Criminalising
people who self-manage their abortions has no
societal purpose nor any benefit for womxn’s
health.
In contrast, under the Irish and New Zealand
laws (2019 and 2020), it is no longer a crime for
a pregnant person to have an abortion, even if
they do so outside of the provisions of the Act.
Yet, these laws overlook a large proportion of
this “constellation of actors”; family members,
friends, support networks or doulas that assist in
the procurement of an abortion outside of the
procedures set by law can still be criminalised
for doing so.52,53 For example, in Rwanda,
womxn who have obtained illegal abortions
have been pardoned, but those who aided them
continue to serve full sentences.54 The criminalisa-
tion of those who assist goes well beyond the
harms the law aimed to address (coerced abor-
tion). It creates a stand-alone crime (that does
not exist for any other medical matter), further
exceptionalising abortion when these concerns
could easily have been covered by general crim-
inal law and professional regulations.
Additionally, laws and policies create vulner-
abilities and risks for those engaged in the prac-
tice by overregulating access to medicines or
restricting the dissemination of information on
how to use them. In the United States and North-
ern Ireland,55 womxn have been prosecuted for
searching for56 or ordering abortion pills online
for their pregnant daughters. The charges in the
US included “providing abortion without a medi-
cal license, dispensing drugs without being a phar-
macist, assault and endangering the welfare of a
child”.57 In Uruguay, a number of people were
prosecuted for illegally selling misoprostol as the
drug is only available within the formal healthcare
system and not sold in commercial pharmacies
under any indication.58 While these legal develop-
ments have expanded some abortion access, the
shortcomings are significant. Laws that criminalise
assistance undermine long-standing practices of
feminist solidarity in the form of provision of
information or pills that have enabled womxn in
many other jurisdictions – from Chile to Ireland
to Poland – to navigate some of the most restric-
tive abortion laws.20
Even when the threats do not yield convictions,
criminalisation results in further stigma, restric-
tion of information, restriction of access to essen-
tial medicines and creates a chilling effect on
these practices.59 Laws and regulations that
apply to SMA may not even be as restrictive as pro-
secutors or law enforcement’s interpretations
suggest. However, they contribute to a widespread
social criminalisation whereby health care person-
nel refuse to provide care or call the police,60
NGOs are raided, and activists are harassed,61
creating an insidious misperception of abortion
as conduct that is criminal at all times. These
medically and legally unnecessary restrictions
exacerbate inequities and risks by enabling actors
who seek to benefit from these restrictive environ-
ments. For example, it exposes womxn to financial
hardship and social/health risks due to higher
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prices for MA, counterfeited drugs, misinforma-
tion (such as the “abortion reversal” pill) and
fake clinics that profit from these restrictive
environments.
While simultaneously having an “alegal”
approach to realising the human right to abortion
and organising trainings for lawyers and legal sup-
port for those that encounter legal trouble, femin-
ist collectives resist the cacophony of laws and
propose models of abortion advocacy that eschew
formal legal mechanisms.62
As countries reform their regulations in the
context of the COVID-19 pandemic and increas-
ingly adopt models of telemedicine similar to
those long used by activists and feminist networks,
the legal restrictions become even more cacopho-
nous. For example, the UK’s new guidelines under
the COVID-19 pandemic allow womxn to manage
their own abortions. Under the new regulations,
those requiring abortion care can access a teleme-
dicine consultation with a registered medical
practitioner, receive MA pills by post and use
them at home.17 While acknowledging the differ-
ences between the philosophies, power dynamics
and models of care underpinning the work of acti-
vists and feminist networks, and that of the medi-
cal model of care, we point out that the process,
active involvement of pregnant persons and the
medicines used in telemedicine are not funda-
mentally different from the care that informal
networks such as the Con las amigas y en la casa
(Chile) and Las Comadres (Ecuador) and other fem-
inist groups have been providing for decades.
However, the legal risks are significantly different.
For example, the care provided for womxn in
Northern Ireland55 was broadly similar but saw
police raids in response. It raises the crucial ques-
tion of why telemedicine within formally recog-
nised systems is treated differently under the
law, compared to those who have provided tele-
health care informally for years before. This is par-
ticularly stark when the quality of medical care in
informal spaces is on a par with formal stan-
dards63,64 and it is the work of activist networks
that has transformed the discourse, technology
and science behind the telemedicine model.
When considering womxn’s documented fears
of judgement and stigma within formal health sys-
tems, feminist abortion care-work caters to their
needs across different quality dimensions.
Grounded in feminist care models, it is these fem-
inist networks’ years of frontline work, research,
innovation and experience that have spurred
telemedicine within formal spaces. Yet, it is
these feminist models that continue to bear a
range of threats and continued questions on the
quality, safety and efficacy of the care they pro-
vide. This schism demonstrates how the law and
criminalisation are tied to the control of abortion,
posing the question, “what/who exactly are we
legitimising and why?”
Quite differently, the law has not been so zeal-
ous in its quest for overregulation of those who
disseminate abortion misinformation65 or the
prosecution of those who harass womxn outside
clinics or online; and have – in some contexts –
passed laws outright that legally require doctors
to tell their patients that “reversal” of MA is an
option, going against all scientific evidence.66
The SMA landscape as we know it now would
not exist without the hard work and risks taken
by feminist organisations and networks that
have served womxn for decades. Any attempt of
regulation must account for their work, include
them and must not place further restrictions on
their work. For years now, there has been a call
for providing abortion in simpler, less medicalised
ways that centre womxn’s needs. The pioneering
work of hotlines, web-based services and feminist
networks demonstrates that this is a real possi-
bility; indeed, it occurs every day within informal
and often illegal set-ups the world over. Feminist
networks, online counsellors, acompañantes and
many of the other models proposed by these
actors have been instrumental in advancing scien-
tific knowledge and transforming the model of
care for abortion. We need to be very vigilant
with regard to laws that attempt to regulate
SMA, that medicalise it by incorporating a series
of unnecessarily burdensome steps or that create
vulnerability for the actors involved in safe self-
management.
Conclusion
The history of MA shows us how informal networks
have discovered, shared and created the space for
SMA to flourish, from Brazilian womxn in the
1980s discovering misoprostol as an abortifa-
cient67 to the Abortion Without Borders coalition
in 2020.20 They have not just enabled the “stra-
tegic life choices which are critical for people to
live the lives they want”68 but have created spaces
for innovation, hope and joy. It is these actors who
have pushed for the shifts we now see in formal
service provision, who have paved the way for
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better quality care and access. And it is these con-
stellations of actors who, when confronted by a
cacophony of laws and increased restrictions, con-
tinue to centre pregnant persons and provide/
enable SMA against the odds, while risking crimi-
nalisation. The constellation of actors, while
advancing access to abortion in a range of legal
and social conditions, have also fundamentally
challenged and altered the meanings of abortion
and abortion provision itself: from whose auth-
ority and knowledge is valued and centred, to
the environments in which abortion is possible,
to issuing a broader challenge around how abor-
tion itself is understood and depicted.
Recognising the importance of centring
people’s trajectories also means accounting for
the constellation of actors that play crucial roles
in these experiences. We argue that within SMA
research, advocacy and policy, without losing
focusing on the “self”, it is important to expand
our focus on “management”. The navigation
towards safely self-managing abortions includes
a huge array of actors, playing key roles, and
they should not be made vulnerable by restrictive
laws and regulations. These key actors, often
working at the frontlines of SMA, are now the tar-
gets of politically motivated prosecutors that
experiment with a variety of laws to punish not
only those who end their own pregnancies but
those who support them.59 Safety, at the very
least, requires accounting for both the outcomes
of the procedure and the conditions under
which an abortion is obtained.15 Thus, we also
need to account for the groups of people that
are crucial to the process of SMA, who risk their
lives, jobs, personal safety, freedom and more
by participating in the process of abortion care
assistance, procurement and provision.
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